Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Development of Tenofovir Prodrugs as Rectal Microbicides for HIV Prevention

Lyu, Yafei (2016) Development of Tenofovir Prodrugs as Rectal Microbicides for HIV Prevention. Master's Thesis, University of Pittsburgh. (Unpublished)

PDF (Thesis)
Submitted Version

Download (2MB) | Preview


Receptive anal intercourse is common among men who have sex with men (MSM), transgender women, and practiced by women around the world. The risk of becoming infected with HIV through receptive anal intercourse is 20 times greater than vaginal intercourse. Hence, there is an urgent need for the development of rectal specific topical pre-exposure prophylaxis (PrEP) products. In the current study, our lab developed enemas containing tenofovir (TFV) for rectal application, which may provide some advantages with respect to user acceptability and compliance. In addition to evaluation of TFV in enemas, prodrugs of TFV: tenofovir alafenamide fumarate (TAF) and hexadecyloxypropyl (HDP)-tenofovir (CMX157) were evaluated due to their increased potency and better safety profile. In this project, a high performance liquid chromatography (HPLC) method for TAF was developed and qualified. Preformulation studies for TAF including solubility, hydrolytic, thermal, photolytic, and oxidative stability and preservative compatibility were conducted. TAF was found to be susceptible to hydrolytic degradation in acidic pH (pH≤4) and degraded when exposed in an aqueous solution to temperatures greater than 25°C. TAF hypotonic and isotonic enema formulations (1.76 mg/mL) were developed and characterized with respect to pH, osmolality, and drug content. One-week stability of these enemas was assessed in 40°C/75% RH, 30°C/65% RH and 25°C/60% RH environmental chambers. TAF enemas were stable for one week. In addition to the TAF enema, formulation efforts were initiated with CMX157. A preliminary HPLC method for CMX157 was developed. Prototype CMX157 enemas were prepared and pH and osmolality testing conducted. Additional formulation optimization is required to enhance TAF stability in an enema format. Further investigation of the prototype CMX157 enema developed with respect to its physiochemical characteristics and stability is needed.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Lyu, Yafeiyal86@pitt.eduYAL86
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairRohan,
Committee MemberSant, VinayakVIS45@pitt.eduVIS45
Committee MemberPoloyac, Samuelpoloyac@pitt.eduPOLOYAC
Date: 10 August 2016
Date Type: Publication
Defense Date: 28 July 2016
Approval Date: 10 August 2016
Submission Date: 9 August 2016
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Number of Pages: 63
Institution: University of Pittsburgh
Schools and Programs: School of Pharmacy > Pharmaceutical Sciences
Degree: MS - Master of Science
Thesis Type: Master's Thesis
Refereed: Yes
Uncontrolled Keywords: Enema, TAF, CMX157, rectal microbicide
Date Deposited: 10 Aug 2016 12:26
Last Modified: 15 Nov 2016 14:35


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item